Stocks · Health care · Pharmaceutical Preparations

PLIANT THERAPEUTICS, INC.

PLRX Clue Score31
United States Fiscal year ends December CIK 0001746473 Results filed 11 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Keith Lamont Cummings
2 May 2024
Chief Financial Officer
Exercised, kept
21,000
$2.08
$43.68K
Keith Lamont Cummings
13 Jun 2023
Chief Financial Officer
Exercised, kept
30,750
$2.08
$63.96K
Keith Lamont Cummings
9 Jun 2023
Chief Financial Officer
Exercised, kept
5,800
$2.08
$12.06K
Keith Lamont Cummings
22 Dec 2022
Chief Financial Officer
Exercised, kept
4,000
$2.08
$8.32K
Keith Lamont Cummings
3 Sep 2021
Chief Financial Officer
Exercised, kept
20,000
$2.08
$41.60K
Hans Hull
26 May 2021
Chief Business Officer
Exercised, kept
4,500
$2.08
$9.36K
Bernard Coulie
13 Apr 2021
President and CEO
Exercised, kept
6,000
$2.08
$12.48K
Keith Lamont Cummings
5 Mar 2021
Chief Financial Officer
Exercised, kept
20,000
$2.08
$41.60K
Hans Hull
30 Dec 2020
Chief Business Officer
Exercised, kept
3,500
$2.08
$7.28K
Keith Lamont Cummings
21 Dec 2020
Chief Financial Officer
Exercised, kept
4,500
$2.08
$9.36K
Bernard Coulie
30 Apr 2020
President and CEO
Exercised, kept
48,227
$2.08
$100.31K
Bernard Coulie
30 Apr 2020
President and CEO
Exercised, kept
613
$6.22
$3.81K
Keith Lamont Cummings
30 Apr 2020
Chief Financial Officer
Exercised, kept
19,300
$2.08
$40.14K

What was left out

Form 4 filings counted 189
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 34
Sales straight out of an exercise 38
Sales at will 31
Transactions with no price 0
Shares from compensation/vesting 16,043,681
Sales filed before the plan box existed 31
History held since 9 Jun 2020